Nasdaq Hearings Panel grants Healthcare Triangle continued listing with reverse stock split and bid price conditions

Healthcare Triangle, Inc.

Nasdaq Hearings Panel granted Healthcare Triangle continued listing on July 2, 2025, finding compliance with shareholders' equity rule and declining delisting.
Company must effect a reverse stock split by August 8, 2025 at a ratio sufficient to achieve long-term compliance with the bid price rule.
By September 5, 2025, Healthcare Triangle must demonstrate compliance with the $1.00 minimum bid price for 20 consecutive trading days.
A discretionary panel monitor will be imposed for one year after regaining compliance with the bid price rule.
Chairman Dave Rosa expressed gratitude and optimism for executing strategic growth plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.